KCL-286

• Target :

  Retinoid Receptor

• Related Pathways :

  Metabolism

• Purity :

  >99.99%

• Bioactivity :

  KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI) .

• Smiles :

  O=C(O)C=1C=CC(=CC1)C2=NOC(=N2)C=3OC=4C(C3)=C(C=CC4C)C

• Molecular Formula :

  C19H14N2O4

• Molecular Weight :

  334.33

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1952276-71-9